From filing to price impact: microstructure, currency-normalised comparisons, walk-forward design.
Five Star Bancorp drew two director buys on July 22. Read the $5.6m cluster against regional bank strength, rates, and peer trading.
Roche lifted H1 sales 6% at constant rates and held guidance. Novartis sets the peer frame, while Roche’s insider record stays quiet.
Roche held 2026 guidance after H1 sales of CHF 30.36 billion. Novartis is the cleaner comp, and Roche has no insider prints in 3 months.
Roche lifted guidance after H1 sales grew 6% at constant rates. Novartis is the cleaner peer check, while insider filings have been quiet.
State Street’s CEO and an EVP sold on July 21 near record highs. Here is how the filings look against custody-bank momentum and rates.
3M’s July 22 insider sales came after a sharp post-earnings rally, with industrials still backed by AI buildout, defense and electrification.
ABC Arbitrage’s July sales came as European financials swung on inflation and rates. Here is how the filings fit the business model.
Samsara CEO Sanjit Biswas sold EUR 5.1m on July 23 as tech sold off and IOT fell 5.52%. Here is the filing against the backdrop.
Agnico Eagle bought EUR 9.76m of Talamore shares on July 22 as gold cools, peers wobble, and Coffee stays the real test.
StoneX CFO William J. Dunaway and CEO Philip Andrew Smith sold after July 22 option exercises, while sector strength and macro volatility frame the trade.
Vivendi’s July 22 buy from Vincent Bolloré lands after the Paris court ruling, with a six-insider cluster and a weak share price backdrop.
ASML raised 2026 sales guidance to €43bn-€45bn after €9.33bn Q2 revenue. Here is how that stacks up against Intel, the sector, and insider activity.